RSS

The Children's Hospital of Philadelphia

The FDA has accepted an investigator-sponsored investigational new drug application for a Phase IIA clinical trial for the potential treatment of milk-induced eosinophilic esophagitis in children using DBV Technologies' Viaskin milk. more

News